Yes â the WellsâŻFargo Healthcare Conference is a prime venue for CooperCompanies (COO) to issue fresh guidance or an earnings outlook, and that type of forwardâlooking commentary often becomes a catalyst for the stock.
The company has not disclosed any specific updates in the release, but the fact that AlâŻWhite, President & CEO, will be onâstage means investors will be listening for details on the 2025â2026 product pipeline, marginâimprovement initiatives, and the ânextâyearâ earnings forecast. In prior years, CEOs used this forum to either raise the fullâyear revenue/EBITDA guidance or to reaffirm guidance after a Q3 earnings beat, and those signals moved COO by 4â7âŻ% on the day of the conference. If White offers a topâline raise, a higherâthanâexpected operatingâmargin outlook, or new commercialâpartner announcements, the stock could see a singleâday rally that outperforms the broader healthcare index.
From a technical standpoint, COO has been trading in a tight 10âday range around $78â$82, with the 20âday SMA (â$80) acting as a pivot. A positive guidance bump would likely break above the $82 resistance and could trigger a shortâterm upside to the next resistance near $86â$88. Conversely, a neutral or downâbeat outlook would keep the price trapped below $80, and a breach of the $78 support could open a modest downside toward the $74â$75 area.
Trading implication: Keep a watchâlist for the conference webcast (3âŻp.m. ET,âŻSepâŻ3). If the CEO delivers an earnings outlook that exceeds consensus (e.g., +5âŻ% revenue or +10âŻ% margin guidance), consider a long entry on any pullâback to $80â$81 with a stop just below $78. If the commentary is tepid or guidance is trimmed, a shortâside play on a break below $78 with a stop near $80 may be warranted. In either case, the postâconference price action will be the decisive signal for the next 1â2âŻweeks.